2005
DOI: 10.1038/sj.mp.4001719
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia

Abstract: We previously reported that expression level of LIM (ENH, PDLIM5) was significantly and commonly increased in the brains of patients with bipolar disorder, schizophrenia, and major depression. Expression of LIM was decreased in the lymphoblastoid cells derived from patients with bipolar disorders and schizophrenia. LIM protein reportedly plays an important role in linking protein kinase C with calcium channel. These findings suggested the role of LIM in the pathophysiology of bipolar disorder and schizophrenia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
44
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(50 citation statements)
references
References 37 publications
6
44
0
Order By: Relevance
“…our finding of strong gene cluster contribution for UBE3A in schizophrenia is intriguing in view of multiple reports that genomic imprinting may play a role in disease etiology (VeenstraVanderWeele et al 1999;Nurmi et al 2001;Jiang et al 2004). Gene expression and association analyses of PDLIM5 (which for us lies in the overlap between bipolar disorder and schizophrenia) suggest its involvement in the etiology of bipolar disorder and schizophrenia (Kato et al 2005), and RAPGEF4 (in the bipolar disorder and autism overlap genes) has been related to the autistic phenotype (Bacchelli et al 2003). Intriguingly, many of our candidate genes have been analyzed in relation to Alzheimer's disease: BLMH (Nivet-Antoine et al 2003); MAPK8IP1 (Helbecque et al 2003); MAPKAPK2 (Culbert et al 2006); LPL (Blain et al 2006); NEFM (Wang et al 2002); FRK (Watanabe et al 2004); and KCNIP3 (Jin et al 2005).…”
Section: Genome Research 1155mentioning
confidence: 87%
“…our finding of strong gene cluster contribution for UBE3A in schizophrenia is intriguing in view of multiple reports that genomic imprinting may play a role in disease etiology (VeenstraVanderWeele et al 1999;Nurmi et al 2001;Jiang et al 2004). Gene expression and association analyses of PDLIM5 (which for us lies in the overlap between bipolar disorder and schizophrenia) suggest its involvement in the etiology of bipolar disorder and schizophrenia (Kato et al 2005), and RAPGEF4 (in the bipolar disorder and autism overlap genes) has been related to the autistic phenotype (Bacchelli et al 2003). Intriguingly, many of our candidate genes have been analyzed in relation to Alzheimer's disease: BLMH (Nivet-Antoine et al 2003); MAPK8IP1 (Helbecque et al 2003); MAPKAPK2 (Culbert et al 2006); LPL (Blain et al 2006); NEFM (Wang et al 2002); FRK (Watanabe et al 2004); and KCNIP3 (Jin et al 2005).…”
Section: Genome Research 1155mentioning
confidence: 87%
“…Previous genetic association studies of PDLIM5 SNP rs2433320 showed significant association in BPD [18], schizophrenia [16] and major depression [17].…”
Section: Discussionmentioning
confidence: 99%
“…The involvement of PDLIM5 in mental disorders was supported by genetic association studies that relate several polymorphisms on PDLIM5 with mental disorders. For examples, the single nucleotide polymorphism (SNP) rs2433320 is associated with schizophrenia [16], major depression [17] and BPD [18][19][20]. Moreover, PDLIM5 SNP rs2433322 has been found associated with schizophrenia [17] whereas another SNP, rs2438146 is associated with BPD in its allelic frequencies but not genotype frequencies [18].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several lines of evidence suggest PDLIM5 as a candidate gene for both schizophrenia (SZ) and bipolar disorder (BP). First, PDLIM5 is significantly upregulated in postmortem brains of patients with SZ or BP from the Stanley Medical Research Institute's (SMRI) brain collections (Iwamoto et al, 2004b;Kato et al, 2005) and abnormally expressed in the peripheral leukocytes derived from patients with each disorder (Iwamoto et al, 2004a;Numata et al, 2007). Second, PDLIM5 is an adopter protein interacting with N-type calcium channel (Maeno-Hikichi et al, 2003), a signaling pathway implicated in the pathophysiology of BP (Warsh et al, 2004).…”
Section: Introductionmentioning
confidence: 99%